- Home
- ITGR vs CLDX Comparison
ITGR vs CLDX Comparison
Compare ITGR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITGR | CLDX |
|---|---|---|
| Founded | 1970 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2000 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ITGR | CLDX |
|---|---|---|
| Price | $93.89 | $35.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $91.14 | $46.60 |
| AVG Volume (30 Days) | 352.1K | ★ 913.4K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $1,853,637,000.00 | $12,743,000.00 |
| Revenue This Year | $1.69 | $111.39 |
| Revenue Next Year | $6.53 | $235.85 |
| P/E Ratio | $194.00 | ★ N/A |
| Revenue Growth | 7.98 | ★ 87.78 |
| 52 Week Low | $62.00 | $19.52 |
| 52 Week High | $123.49 | $35.83 |
Technical Indicators
Market Signals| Indicator | ITGR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 62.80 |
| Support Level | $82.58 | $28.51 |
| Resistance Level | $94.76 | $35.10 |
| Average True Range (ATR) | 2.37 | 1.23 |
| MACD | 0.02 | 0.43 |
| Stochastic Oscillator | 80.25 | 78.89 |
Price Performance
Historical ComparisonAbout ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.